Modular Peptide Nanoparticle Delivery via Endosomal Escape
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for intracellular delivery of quantum dots and nanoparticles are either non-specific and inefficient, or invasive and toxic, often resulting in sequestration within endocytic vesicles rather than release into the cytosol.
Innovation Solution
A polypeptide with specific domains for nanoparticle association, spacer, uptake, and vesicle escape, including a non-hydrolyzable lipophilic moiety, facilitates the uptake and delivery of nanoparticles to the cytosol by inducing endosomal escape.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If passive delivery or facilitated delivery methods are used, then nanoparticle uptake is achieved, but the nanoparticles are sequestered within endocytic vesicles and not released into the cytosol
Solution Approach 1:
The delivery system is segmented into distinct functional domains within the peptide: an uptake domain for cellular internalization, a spacer domain for structural separation, and a vesicle escape domain for endosomal disruption. This segmentation allows each domain to perform its specific function independently, achieving cytosolic delivery without requiring complex external intervention mechanisms.
Solution Approach 2:
The peptide acts as an intermediary molecule that mediates the entire delivery process from nanoparticle attachment to cytosolic release. The peptide's modular structure serves as a bridge between the nanoparticle and the cellular delivery machinery, facilitating uptake through the uptake domain and subsequent escape from endocytic vesicles through the vesicle escape domain, thereby achieving reliable cytosolic delivery.
2Productivity
If endocytic pathway is utilized for nanoparticle internalization, then cellular uptake is achieved, but additional toxic chemicals or polymers are required to disrupt endosomes
Solution Approach 1:
The uptake function and vesicle escape function are merged into a single peptide molecule. The uptake domain facilitates endocytic internalization while the vesicle escape domain, containing the non-hydrolyzable lipophilic moiety, simultaneously provides the mechanism for endosomal disruption. This merging eliminates the need for separate toxic disruption agents, as the peptide itself performs both functions.
Solution Approach 2:
The peptide is self-sufficient in providing both uptake and escape functionalities. The non-hydrolyzable lipophilic moiety within the vesicle escape domain enables the peptide to autonomously disrupt endosomal membranes without requiring external toxic chemicals or polymers. This self-service capability achieves nanoparticle release into the cytosol without exposing cells to additional cytotoxic substances.
3Reliability
If physical manipulation methods like electroporation are used, then direct cytosolic delivery is achieved, but cellular integrity is compromised and viability is reduced
Solution Approach 1:
The invention changes the delivery mechanism from physical manipulation to biochemical interaction. Instead of using electroporation's high-voltage physical field that compromises cellular integrity, the system uses the peptide's biochemical properties—specifically the uptake domain for receptor-mediated internalization and the lipophilic moiety for membrane interaction—to achieve cytosolic delivery through natural cellular processes, thereby preserving cell viability.
Solution Approach 2:
The mechanical system of electroporation (physical field application) is replaced with a biochemical system based on peptide-nanoparticle conjugates. The peptide's modular structure enables biochemical mediation of uptake and vesicle escape through molecular interactions rather than mechanical force, achieving direct cytosolic delivery without the cellular damage associated with physical manipulation methods.
4Reliability
If non-hydrolyzable lipophilic moiety is added to vesicle escape domain, then endosomal escape is enabled, but peptide structure complexity increases
Solution Approach 1:
The peptide structure is segmented into functional domains, with the non-hydrolyzable lipophilic moiety confined to the vesicle escape domain. This segmentation localizes the structural complexity to a specific functional region rather than distributing it throughout the entire peptide, enabling endosomal escape while maintaining a modular and organized overall structure that facilitates understanding and design.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide-mediated approach enables efficient and minimally toxic delivery of nanoparticles to the cytosol, maintaining long-term stability and minimizing cytotoxicity, allowing for effective intracellular distribution and labeling.
Implementation Method 1
upon addition of a non-hydrolyzable lipophilic moiety to the vesicle escape domain and binding to a nanoparticle
Data Source
AI summary
Described are nucleic acids encoding a polypeptide for delivery of a nanoparticle to the cytosol, the peptide comprising: (a) a nanoparticle association domain, (b) a spacer domain, (c) an uptake domain, and (d) a vesicle escape domain, wherein the domains (a) through (d) appear in the same order as listed above, and wherein the peptide, upon addition of a non-hydrolyzable lipophilic moiety to the vesicle escape domain and binding to a nanoparticle, is effective to induce uptake of a nanoparticle by a cell and delivery of the nanoparticle to the cytosol of the cell. Also described are methods of delivery of a nanoparticle to the cytosol of a cell, the method comprising providing to a cell a nanoparticle attached to such a peptide. Exemplary nanoparticles include quantum dots.